Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)
France flag France · Delayed Price · Currency is EUR
0.3120
-0.0100 (-3.11%)
Last updated: Aug 3, 2026, 3:02 PM CET

EPA:ALOPM Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
68133028-
Market Cap Growth
-24.17%-41.49%-56.98%6.93%--
Enterprise Value
10.419.6821.8730.6221.340
Last Close Price
0.310.410.711.811.70-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
1.071.37----
Forward PE
-0.21----
PS Ratio
3.3829.1062.7328.163.54-
PB Ratio
1.064.03-3.4917.252.87-
P/TBV Ratio
6.758.91-50.063.12-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
5.7475.35105.6428.562.67-
EV/EBITDA Ratio
1.823.45----
EV/EBIT Ratio
1.823.45----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.650.652.652.390.190
Debt / EBITDA Ratio
1.111.11----
Net Debt / Equity Ratio
2.252.25-0.62-0.86-1.09-1.00
Net Debt / EBITDA Ratio
0.740.74-0.300.156.69-
Asset Turnover
0.020.020.020.060.870
Quick Ratio
0.960.962.543.424.10-
Current Ratio
4.764.762.693.504.14-
Return on Equity (ROE)
87.11%87.42%-209.50%-92.93%-3.37%0.00%
Return on Assets (ROA)
44.15%44.15%-49.21%-46.65%-2.35%0.00%
Return on Invested Capital (ROIC)
40.62%59.31%-183.13%-318.17%-14.64%-
Return on Capital Employed (ROCE)
57.98%57.98%-78.04%-73.86%-22.35%0.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
89.38%72.82%----
Buyback Yield / Dilution
-1.34%0.00%-9.06%-0.43%-1660651.40%0.00%
Total Shareholder Return
-1.34%0.00%-9.06%-0.43%-1660651.40%0.00%